Background/Objectives.-Nonpharmacological interventions, such as biofeedback, cognitive behavioral therapy, and relaxation techniques are Level-A evidence-based treatments for headache. The impact of these interventions is often equivalent to or greater than pharmacological interventions, with fewer side effects. Despite such evidence, the rate of participation in nonpharmacological interventions for headache remains low. Once obstacles to optimizing use of behavioral interventions, such as local access to nonpharmacological treatment and primary headache providers are traversed, identification of barriers contributing to low adherence is imperative given the high levels of disability and cost associated with treating headache disorders. In this review of factors in adults associated with underuse of nonpharmacological interventions, we discuss psychological factors relevant to participation in nonpharmacological treatment, including attitudes and beliefs, motivation for change, awareness of triggers, locus of control, self-efficacy, acceptance, coping styles, personality traits, and psychiatric comorbidities associated with treatment adherence. Finally, future prospects and approaches to optimizing treatment matching and minimizing adherence issues are addressed.
INTRODUCTION
Although the efficacy of nonpharmacological interventions to treat headaches has been established, 1 adherence rates are often low, 2 creating challenges in management of headache as a chronic condition. 3 While "compliance" typically refers to patients following recommendations from their health care providers, 4 "adherence" has various definitions. Most originate from Haye's definition, which is "the extent to which a person's behavior coincides with medical or health advice." 5 For the purpose of this paper, we will use the word adherence, although the literature uses both terms, often interchangeably or without differentiation of their meaning. Few studies have evaluated adherence to nonpharmacological headache treatment and the impact of adherence on clinical outcomes. A prospective cohort study of outpatients diagnosed with migraine and referred for behavioral treatment for migraine found that only about half (56.6%) of the patients initiated behavioral migraine treatment. 6 In another study of 221 severe tertiary care headache inpatients who were advised to do relaxation therapy in the 7-day period before discharge, percentages of patients using relaxation on at least 5 of the 7 days were modest; 45% used relaxation during stress, 55% used relaxation during headache, and 59% used relaxation as a preventive measure. 7 An observational study evaluating a 5-day multidisciplinary headache treatment program involved training on lifestyle modification, progressive muscle relaxation (PMR), and physical therapy. After 12-18 months, 61% of patients were adherent to relaxation therapy (PMR) and 72% to aerobic endurance sports. Moreover, adherence to more than 5 lifestyle modifications was associated with at least a 50% reduction in headache frequency at follow-up. 8 In another study, although patient adherence to physician instructions across 4 areas -diet/meal timing, exercise, stress management/sleep modifications, and medications/vitamins was low (14-45%), 9 adherence in all 4 domains was associated with improvement in migraine disability, migraine days, and pain, as well as physician empathy. 9 Despite the association between higher rates of adherence and better clinical outcomes, nonpharmacological treatment adherence remains varied and low. Identification of barriers to initiation and completion of nonpharmacological interventions is thus paramount to maximizing adherence and ultimately maximizing the potential effectiveness of these low risk interventions. 10, 11 This narrative review aims to identify barriers to poor adherence as a first step toward identifying potential targets to improve adherence.
METHODS
An interdisciplinary team conducted this narrative review of barriers to adherence to behavioral therapy for headache treatments. Four neuropsychologists (YM, DL, YSL, and FF) conducted literature searches in PubMed during the month of July 2017 using the following combination of descriptors: ("headache" or "migraine"), and ("adherence" or "compliance") or "barriers to treatment" or the various psychological factors discussed in this narrative review. They synthesized the salient points relevant to nonpharmacological adherence and content experts (MTM, RL, and SP) each provided input and feedback leading to the addition of other pertinent studies. Subsequently, the full team (including a psychiatrist, NMS, and complementary and integrative health specialist, AS) added commentary resulting in integration of noteworthy studies. In addition to abstracts, book chapters, and books addressing headaches and issues relevant to this narrative review were included. As this was not a systematic review with a PICO question, an a priori decision was made to examine studies with adherence as the primary outcome as well as other headache studies that examined barriers to following recommended behavioral interventions.
RESULTS

Barriers to
Adherence.-Attitudes and Beliefs.-A major obstacle to treatment success, defined as 50% reduction in headache frequency, is the patient's set of attitudes and beliefs regarding behavioral interventions. 12 In turn, while studies examining the direct association between attitudes/ beliefs and adherence are limited, existing studies of individuals with headache along with comorbid pain and insomnia have found that treatment acceptability was significantly associated with nonpharmacological treatment adherence. 13 Therefore, perceptions of treatment acceptability may be a possible modifiable target to enhance adherence to nonpharmacological treatment adherence. Smitherman et al provided a comprehensive list of attitudes and beliefs that patients have toward various nonpharmacological headache interventions and possible interventions to minimize barriers to adherence (Table 1 ).
14
Stage of Change Model.-A patient's readiness or motivation to change can influence adherence to treatment and is often represented via the Stage of Change Model (also known as the Transtheoretical Model), 15 which identifies 5 stagesprecontemplation, contemplation, preparation, action, and maintenance. Individuals in the pre-contemplation or contemplation stage may be less likely to adhere to treatment than individuals in the preparation, action, or maintenance stages as the former may be more ambivalent about following through with prescribed treatment (see Table 2 for a fuller description of these stages and ways of interacting with patients appropriate to their stage of change). 22 Similarly, higher internal LOC was associated with greater headache activity reduction 20 months following a biofeedback behavioral program. 23 Moreover, Scharff et al 24 found that external LOC was associated with higher pain intensity, interference with various domains in their lives, and adaptive responses. As such, one might surmise that the association between LOC and outcome is mediated by adherence. In a seminal study of 277 individuals with recurrent headaches, internal LOC was associated with a preference for selfregulation treatment and chance LOC was associated with higher levels of depression, physical symptoms, disability, and maladaptive coping strategies. 20 Additionally, health care professional LOC was linked to preference for medical treatment and higher levels of medication use. Taken together, evidence suggests patients with higher internal LOC may be more likely to adhere to nonpharmacological behavioral interventions with a self-management component. On the other hand, patients with high external LOC, particularly health care professional LOC may be more likely to adhere to pharmacological treatment. Thus, individual differences in LOC may be important to assess (see Table 3 for validated measures) in order to maximize adherence.
Self-Efficacy.-Self-efficacy, the belief that one can successfully engage in a course of action to produce a desired outcome, is another psychological process long recognized to interact with headache treatment outcomes. [25] [26] [27] Within the context of headache management, headache self-efficacy is defined as perceiving oneself capable of taking actions that will prevent or improve headache episodes. 28, 29 Though review of existing publications reveals a paucity of research directly examining associations between self-efficacy and nonpharmacological treatment adherence, available data indicate that greater levels of self-efficacy are associated with greater adherence to both preventative 30 and acute pharmacological treatment. 31 Further, self-efficacy mediated the association between pain severity and disability 32, 33 and may be an important mechanism in pain reduction. 34 For example, French et al 35 found
that self-efficacy scores were positively associated with use of adaptive coping efforts to both prevent and manage headache episodes among 146 individuals with diagnoses of tension-type headache or comorbid tension and migraine diagnoses. In contrast, low self-efficacy has been linked with less effective coping strategies and outcomes. Low self-efficacy was associated with use of passive coping strategies, such as problem avoidance, wishful thinking, social withdrawal, and self-criticism in a sample of 153 college students with either tension or migraine • Brief Psychiatric Rating Scale (BPRS) 80 • Symptom Checklist-90-R (SCL-90-R) 81 • Generalized Anxiety Disorder -7 Item Scale (GAD-7) 72 • Patient Health Questionnaire -9 (PHQ-9) 73 headache. 28 More recently, a systematic review found moderate evidence indicating that low selfefficacy was a potential prognostic indicator for poor outcome in treating chronic headache. 36 These associations have led researchers to hypothesize that self-efficacy is critical for headache management, as lower self-efficacy may portend low adherence. 5 Thus, assessing and targeting self-efficacy (see Table  3 for validated self-efficacy measures and Table 1 for strategies to facilitate self-efficacy) is recommended in order to facilitate adherence and responsiveness to nonpharmacological headache interventions.
Coping Styles.-Individuals learn and utilize a variety of coping strategies to manage pain including relaxation, distraction, reappraisal, and seeking emotional support or spiritual comfort. 37 According to Lazarus and Folkman, such coping strategies can be defined as either problem-focused (involves direct action to address the stressor) or emotion-focused (indirect attempts to attend to the psychological consequences of the stressor). 38 Problem focused coping has been found to be effective for managing headaches, in that directly managing the stressful situation itself, generating solutions, and learning new skills to manage stressors reduces psychological distress and pain-related disability. 39 While certain emotion-focused coping strategies such as problem avoidance, self-criticism, wishful thinking, and social withdrawal are often associated with poorer outcomes, 40 other emotion-focused coping styles such as emotional acceptance can be complementary to problem-focused coping. 41 Overall, while a problem-focused coping style is compatible with a skills-based approach suggesting greater likelihood of nonpharmacological treatment adherence, emotion focused coping should be evaluated further. When faced with chronic pain, the natural response may involve avoidance to control the pain. Avoidance, however, can have a paradoxical effect in that prolonged attempts to reduce aversive experiences may actually increase them. 42 Further, unrealistic expectations of perfect headache control may escalate stress and hinder treatment adherence. In addition, there is a growing body of literature on anxiety sensitivity or the fear of arousal-related bodily sensations due to beliefs about presumed negative consequences. 43 Anxiety sensitivity has been found to predict pain and adjustment to pain 44 and has been considered a vulnerability factor for the engagement in fear and avoidance behaviors. 45 Knowledge of patient beliefs about ability to control pain as well as anxiety sensitivity is useful in generating a specific treatment plan and is targeted in treatments such as acceptance and commitment therapy (ACT). In this treatment approach, acceptance is defined as "willingness to experience psychological states as they are." 46 More specifically, pain acceptance is conceptualized as having 2 components: (1) pain willingness, which is recognition that efforts to avoid or control pain are usually ineffective, and (2) activity engagement or the pursuit of life activities in a normal manner despite pain. 47 Randomized controlled trials have shown that ACT is effective for chronic pain management. 48 In one study, a 1-session (5 hour) group ACT workshop and headache education was compared to treatment as usual (TAU) for patients with migraine and comorbid depression. 49 At 12-week follow-up, ACT participants demonstrated significantly greater reductions in both depressive symptoms and headache-related disability. 49 In a separate publication reporting the effects of an ACT plus Migraine Education (ACT-ED) workshop vs treatment as usual (TAU) on headache, the ACT-ED group demonstrated significantly greater reductions than the TAU group in headache frequency, headache severity, and use of acute medications for headache at 3-month follow-up. 50 Other studies have found that individuals with lower levels of pain acceptance report greater pain-related interference, catastrophizing, and disengagement from activities 51 as well as depression and disability. 52 Theoretical considerations and extant evidence from acceptance-based interventions suggest that adherence may be improved by targeting an individual's beliefs and behavior related to pain avoidance and control. In turn, adherence to acceptance-based interventions may be improved by changing the focus from perfect pain control to improving function by facilitating engagement in activities despite pain.
Psychiatric Comorbidities.-Adherence to nonpharmacological headache treatment recommendations may be hindered by comorbid psychiatric conditions. For example, meta-analyses of anxiety disorders have reported nonadherence in the range of 9-21% for cognitive behavioral therapy (CBT: across meta-anal-yses, M = 16%). 53 Studies examining CBT for depression and anxiety have also revealed nonadherence rates of approximately 20-30%. 54, 55 Thus, individuals who require treatment for comorbid psychiatric conditions face multiple psychosocial factors that complicate adherence. As such, addressing comorbidities, such as anxiety or depression, which may contribute to avoidance behaviors or impact motivation may be helpful. Therefore, given the diversity of the psychiatric comorbidities with migraine and the differing treatment considerations, one needs to take into account psychiatric comorbidities when considering adherence for nonpharmacological treatment for migraine (see Table 3 for screening measures). Enhancing Adherence.-We have set forth several points above regarding psychological aspects, which can present as major obstacles to nonpharmacological treatment adherence. The following are some potential evidence-based and theoretical ways in which adherence might be facilitated.
Address Ambivalence to Treatment.-Certain attitudes and beliefs toward headache nonpharmacological treatment can be assessed in order to increase adherence once treatment is initiated. Smitherman et al. have provided a comprehensive list of patient attitudes and beliefs toward various headache nonpharmacological interventions and possible strategies clinicians can utilize to address various concerns (See Table 1 ). 14 Nicholson outlined the importance of the clinician's ability to understand and shape headache nonpharmacological treatment based on the patient's readiness to change. 17 56 that focuses on clinician and patient collaboration to cultivate changes without the clinician imposing judgment. This intervention effectively promotes selfefficacy, coping with resistance, and exploration of any ambivalence associated with headache management. Strategies for MI include using open-ended questions to elicit self-motivational statements and behavioral change from the client in addition to creating client discrepancy between behaviors and statements to enhance motivation for positive change. 56 Furthermore, patients' strengths to increase selfefficacy are affirmed. 56 Treatment Matching.-A more formal potential approach to increasing adherence is treatment matching, which tailors treatment to the patient characteristics, preferences, symptoms, motivation, readiness to change, and level of severity. 57 While these factors are important to consider when referring patients for nonpharmacological headache interventions, limited algorithms have been created to match interventions with headache patients' profiles. 57 Treatment matching has been utilized more in other populations, such as individuals with substance abuse. Although no matching criteria have been developed for the headache population, Lipchik et al suggested 2 techniques to study headache treatment matching: patient typologies and Aptitude Treatment Interaction (ATI).
57
The patient typologies methodology uses statistical analysis to identify clusters of patient profiles, the underlying assumption being that each patient's profile predicts different treatment needs and the approach that should result in the greatest treatment gains. 57 For instance, headache patients can be grouped into 5 clusters: (i) "just painful" patients (those without significant behavioral disturbances), (ii) anxious, depressed, and mildly-moderately affected patients, (iii) patients misusing medications, (iv) patients overusing headache medications, and (v) patients with personality disorder(s). 58 The need for treatment matching with patient typologies is supported by the fact that ineffective interventions can negatively affect treatment adherence. 59 For example, a directive approach with cognitive behavioral therapy can be counterintuitive for patients with narcissistic or borderline personality disorder. 60 Drawbacks are that patient typologies are not informed by actual patient response data and it can also be problematic when patients do not clearly fall under any of or more than one of the clusters. 61 Further, various psychological factors noted previously (eg, locus of control, self-efficacy, etc) are not considered in typologies. ATI methodology focuses on predicting treatment outcomes based on a critical aptitude or characteristic. Common patient aptitudes examined include (1) patient demographic variables, (2) headache severity, chronicity, type, and disability, (3) psychiatric co-morbidities, and (4) psychological factors, such as self-esteem, coping styles, and motivation for treatment. Typically, individuals with more of a certain aptitude or characteristic would benefit and adhere to a particular treatment, while individuals with less would potentially benefit from a different type of treatment. One drawback of this approach is that if too many variables are analyzed and the statistical power is poor, results will not be interpretable. 57 Thus, it is crucial for researchers and clinicians to conduct a power analysis to identify therapy-specific predictors that are strong in theoretical validity. 57 Figure 1 provides a sample of factors that can be considered for ATI analysis.
Utilization of Psychiatric/Personality Assessment Tools.-Evaluation of personality traits and psychiatric symptoms with objective standardized assessment tools can identify comorbid psychiatric disorders that may contribute to headache chronicity. [62] [63] [64] As noted before, individuals who require treatment for comorbid psychiatric conditions face multiple psychosocial factors that complicate adherence, which suggests the importance of assessing comorbidities. While the MMPI is a well validated and commonly used measure to assess personality traits, studies examining the utility of the MMPI among individuals with headache to predict adherence are limited. Of existing studies utilizing the MMPI, many have examined the prognostic role for pretreatment MMPI scores in treatment outcome rather than adherence. 65, 66 A more recent study with a longer follow-up than prior studies found that the group who showed 50% reduction in headache 2 years after treatment had significantly lower baseline MMPI-2 scores on scales indicative of excessive somatic focus (ie, elevations on scales 1, 2, 3) on non-reality-based thoughts compared to treatment nonresponders. 67 While there is also a growing body of literature examining personality traits associated with adherence for medication overuse headache detoxification, [68] [69] [70] studies on personality and nonpharmacaological headache treatment adherence are scarce. One study examined utilization of the MMPI as a prognostic indicator of adherence and found that individuals with either tension or migraine headache who had higher scores in scales characterized by antisocial, paranoid, or manic tendencies were more likely to terminate biofeedback and relaxation training prematurely. 71 Utilization of the MMPI may not be practical in most clinical settings given the amount of time required to administer, score, and interpret the measure. Therefore, screeners such as Generalized Anxiety Disorder -7 item (GAD) 72 or the Patient Health Questionnaire -9 (PHQ-9) 73 may be a valuable alternative to assess psychiatric comorbidities. Altogether, these findings suggest that examining personality traits and characteristics with measures such as the MMPI or other validated measures of personality traits and psychiatric symptoms (Table 3) has some clinical utility in choosing appropriate treatment for headache populations, with relevance for adherence and treatment responsiveness.
CONCLUSIONS
Despite a growing body of literature demonstrating positive outcomes among individuals who adhere to nonpharmacological treatment, adherence to such treatments remains an issue. Indeed, initial considerations include obstacles that contribute to under-utilization of nonpharmacological interventions. Such factors include limited availability of primary headache providers offering appropriate interventions or referrals as well as health care providers trained in nonpharmacological treatment. Once above factors are addressed, adherence becomes an issue. The focus of this narrative review was to examine ways in which various psychological factors and psychiatric comorbidities may compromise treatment adherence. Furthermore, potential methods to enhance treatment adherence were discussed.
Various psychological factors such as attitudes or beliefs, lack of motivation, poor awareness of triggers, external locus of control, poor self-efficacy, low levels of pain acceptance, and engagement in maladaptive coping styles can all contribute to nonadherence. To maximize adherence, clinicians can begin by assessing an individual's perception of nonpharmacological treatment acceptance by initiating a dialog and asking for patient's thoughts or reactions regarding such interventions. Any problematic attitudes and beliefs that may present as barriers should be addressed by providing education, encouragement, and by managing expectations, etc (see Table 1 for possible interventions). Further, clinicians can assess readiness for change and utilize motivational interviewing techniques for individuals in the pre-contemplation or contemplation stage including providing headache psychoeducation to assist in increasing awareness of the benefits of managing their headaches (see Table 2 ). Additionally, brief measures to assess locus of control and self-efficacy can be utilized to guide ideal treatment approach (see Table 3 ). Further, given psychiatric comorbidities that are associated with headache can impact treatment nonadherence, 53 ,74 a comprehensive assessment and history-taking is of utmost importance (see Table 3 ). Developing personalized treatment approach based on assessment of the above psychological and psychiatric factors and utilizing treatment matching approaches such as those proposed by Lipchik et al 57 may maximize adherence. For example, understanding that individuals with higher internal locus of control may be more receptive to nonpharmacological intervention as opposed to individuals with external locus of control whose preference may be for pharmacological treatment can facilitate successful treatment allocation. Furthermore, given theoretical considerations and extant evidence that adaptive coping may promote adherence to nonpharmacological interventions for headache, evidence-based interventions targeting dysfunctional coping skills may promote treatment adherence. As an example, combining problem-focused and adaptive emotional coping skills, such as pain acceptance may be potentially beneficial. 41 The inverse relationship between levels of pain acceptance and interference in daily activities 51, 52 supports the importance of efforts to increase pain acceptance by implementing flexible behavioral responses to pain, rather than focusing on pain reduction. While growing, adherence research for nonpharmacological headache treatment remains scant. Understanding and addressing factors associated with adherence is paramount to improving clinical outcome. Future studies might utilize treatment matching algorithms by considering psychological and psychiatric factors in order to assess adherence rates with more personalized approach. For example, based on patient typologies and ATI as discussed by Lipchik et al, 57 creating a patient-treatment matching protocol consisting of various intervention modules (eg, CBT, medication management, trigger management, motivational interviewing, acceptance, and commitment therapy, etc) may be more tailored and tolerated approach to treatment. Attention to the variety of factors that influence adherence is paramount to headache practitioners in promoting treatment adherence and ultimately treatment outcome. 
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